Clinical Trial Update: Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers the pediatric use of temozolomide in combination with peripheral stem cell transplantation for newly diagnosed malignant gliom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Childhood Germ Cell Tumor
• Head and Neck Cancer
• Kidney Cancer
• Neuroblastoma
• Ovarian Cancer
• Sarcoma
• Testicular Germ Cell Tumor

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1, Phase 2 | Status: COMPLETED